| GLYC Market Cap History Table | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Below is a table of the GLYC market cap history going back to 1/10/2014:
Also see: GLYC Shares Outstanding History and GLYC YTD Return |
GLYC Market Cap History — GlycoMimetics Capitalization Over Time
As of 5/12/2025 GlycoMimetics has a market cap of 16.78 million. Investors often follow the GLYC market cap history to compare the size of the company over time.
This page shows GLYC market capitalization trends over time, with 47 market cap datapoints presented, dating back to 1/10/2014.
| GLYC Market Cap History Chart | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
GLYC Historical Market Cap: -17.41% CAGR 
Mouse over chart for data details
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| GLYC Stock Price Chart |
| About Crescent Biopharma Inc |
| GlycoMimetics, Inc. is a late clinical-stage biotechnology company discovering and developing glycobiology-based therapies for cancers, including acute myeloid leukemia (AML) and for inflammatory diseases. It is developing a pipeline of glycomimetics, which are small molecules that mimic the structure of carbohydrates involved in biological processes, to inhibit disease-related functions of carbohydrates, such as the roles they play in inflammation, cancer and infection. Its drug candidates include Uproleselan, GMI-1687, Galectin Antagonists and GMI-1359. We show 47 historical shares outstanding datapoints in our GLYC shares outstanding history coverage, used to compute GLYC market cap on those dates. Understanding the changing numbers of shares outstanding, the changing share price, and the resulting changing GLYC market cap history over the course of time is important for investors interested in comparing GLYC's market cap history versus its peers. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies, and then calculating their respective market caps. Comparing the share price of GLYC versus a peer is one thing; comparing GLYC market cap versus a peer is a completely different story. Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares), the market cap for a company like GLYC can fluctuate over the course of history. With this page we aim to empower investors researching GLYC by allowing them to research the GLYC market cap history. |
| GLYC Current Stock Quote |
Quotes delayed 20 minutes  Free GLYC Email Alerts:
Get Dividend Alerts 
Get SEC Filing Alerts
|
| Video: The Importance of Market Cap | |
|
Video: The Importance of Market Cap
| GLYC Share Performance |
| Market Cap Peers |
| GlycoMimetics (GLYC) is categorized under the Healthcare sector; to help you further research historical market cap numbers, below are some other companies in the same sector:
GMED Market Cap History GMTX Market Cap History GNCA Market Cap History GNLX Market Cap History GNMK Market Cap History GNMX Market Cap History GNPX Market Cap History GOSS Market Cap History GOVX Market Cap History GRAY Market Cap History More Healthcare companies » |
GLYC Market Cap History | www.MarketCapHistory.com | Copyright © 2017 - 2026, All Rights Reserved
Nothing in MarketCapHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel
from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners.
None of the information contained herein constitutes a recommendation that any particular security, portfolio,
transaction, or investment strategy is suitable for any specific person. All viewers agree that under no
circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held
liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you
agree to the following Full Disclaimer & Terms of Use and
Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at
least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
